Oncology CRA: Site Monitoring & Study Start-Up

Oncology CRA: Site Monitoring & Study Start-Up

Full-Time 40500 - 49500 Β£ / year (est.) No working from home possible
BeOne Medicines

At a Glance

  • Tasks: Monitor oncology trials and ensure data quality and compliance.
  • Company: BeOne Medicines, a leader in innovative cancer research.
  • Benefits: Competitive salary, travel opportunities, and professional growth.
  • Other info: Dynamic role with up to 60% travel for site monitoring.
  • Why this job: Join a mission-driven team making a difference in cancer treatment.
  • Qualifications: 2-5 years CRA experience and strong communication skills.

The predicted salary is between 40500 - 49500 Β£ per year.

Be One Medicines is seeking an experienced Clinical Research Associate (CRA) to monitor oncology/hematology trials across the region.

You will perform feasibility, site identification, initiation and ongoing monitoring to ensure data quality and regulatory compliance.

Ideal candidates have 2–5 years of CRA experience, strong communication and organizational skills, and fluency in English.

Travel up to 60% is required; salary range reflects UK market norms.

#J-18808-Ljbffr

Oncology CRA: Site Monitoring & Study Start-Up employer: BeOne Medicines

BeOne Medicines is an exceptional employer, offering a dynamic work culture that fosters innovation and collaboration in the healthcare sector. With a strong commitment to employee growth, we provide ample opportunities for professional development and advancement, particularly in the impactful field of oncology. Located in the UK, our team enjoys a supportive environment where strategic thinkers can thrive and make a meaningful difference in corporate affairs and communications.

BeOne Medicines

Contact Details:

BeOne Medicines Recruitment Team

We think you need these skills to ace Oncology CRA: Site Monitoring & Study Start-Up

Clinical Research Associate (CRA) Experience
Oncology/Hematology Knowledge
Feasibility Assessment
Site Identification
Site Initiation
Ongoing Monitoring
Data Quality Assurance